Effects of a Short Course of Leflunomide on T-Independent B-Lymphocyte Xenoreactivity and on Susceptibility of Xenografts to Acute or Chronic Rejection-Reference-Cited by-同舟云学术

Effects of a Short Course of Leflunomide on T-Independent B-Lymphocyte Xenoreactivity and on Susceptibility of Xenografts to Acute or Chronic Rejection

Published:2005-01-27 Issue:2 Volume:79 Page:135-141
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Yan Yehong,Verbeken Eric,Yu Lisong,Rutgeerts Omer,Goebels Jozef,Segers Constant,Lin Yuan,Waer Mark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference26 articles.

1. Are anti-endothelial cell antibodies a pre-requisite for the acute vascular rejection of xenografts?;Dorling;Xenotransplantation,2003

2. Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions.;Lin;Kidney Int,1995

3. The immunological hurdles to cardiac xenotransplantation.;Platt;J Card Surg,2001

4. T cell and B cell tolerance to Gal alpha 1, 3Gal-expressing heart xenografts is achieved in alpha 1,3galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.;Ohdan;Transplantation,2001

5. Transplantation tolerance and autoimmunity after xenogeneic thymus transplantation.;Xia;J Immunol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfiram treatment suppresses antibody-producing reactions by inhibiting macrophage activation and B cell pyrimidine metabolism;Communications Biology;2024-04-22

2. Mitochondrial iron regulation as an emerging target in ischemia/reperfusion injury during kidney transplantation;Biochemical Pharmacology;2023-09

3. Artemisinin attenuates IgM xenoantibody production via inhibition of T cell‐independent marginal zone B cell proliferation;Journal of Leukocyte Biology;2020-06-15

4. Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4+Foxp3+ T cells in concordant heart transplantation;Laboratory Investigation;2016-06-13

5. B-Cell Targeting Agents in the Treatment of Multiple Sclerosis;Current Treatment Options in Neurology;2013-04-23